The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
The fibrosis-cell death axis in heart failure
Open accessAbstract
Cardiac stress can induce morphological, structural and functional changes of the heart, referred to as cardiac remodeling. Myocardial infarction or sustained overload as a result of pathological causes such as hypertension or valve insufficiency may result in progressive remodeling and finally lead to heart failure (HF). Whereas pathological and physiological (exercise, pregnancy) overload both stimulate cardiomyocyte growth (hypertrophy), only pathological remodeling is characterized by increased deposition of extracellular matrix proteins, termed fibrosis, and loss of cardiomyocytes by necrosis, apoptosis and/or phagocytosis. HF is strongly associated with age, and cardiomyocyte loss and fibrosis are typical signs of the aging heart. Fibrosis results in stiffening of the heart, conductivity problems and reduced oxygen diffusion, and is associated with diminished ventricular function and arrhythmias. As a consequence, the workload of cardiomyocytes in the fibrotic heart is further augmented, whereas the physiological environment is becoming less favorable. This causes additional cardiomyocyte death and replacement of lost cardiomyocytes by fibrotic material, generating a vicious cycle of further decline of cardiac function. Breaking this fibrosis-cell death axis could halt further pathological and age-related cardiac regression and potentially reverse remodeling. In this review, we will describe the interaction between cardiac fibrosis, cardiomyocyte hypertrophy and cell death, and discuss potential strategies for tackling progressive cardiac remodeling and HF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A. C., Yu, C.-M., & Lan, H.-Y. (2014) · Molecular Therapy · doi:10.1038/mt.2014.25 · Cited by 271
RetractedApoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Remodelling the extracellular matrix in development and disease
Bonnans, C., Chou, J., & Werb, Z. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3904 · Cited by 4,367 · cited 2×
“Fibrosis is the excessive deposition of extracellular matrix (ECM), such as collagens and fibronectin, resulting in the excessive accumulation of fibrous connective tissue [1, 2].”
BackgroundMyofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs105 · Cited by 2,644
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Extracellular Matrix Degradation and Remodeling in Development and Disease
Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005058 · Cited by 2,265
Desmoulière, A., Geinoz, A., Gabbiani, F., & Gabbiani, G. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.103 · Cited by 2,243
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Clinical epidemiology of heart failure
Mosterd, A., & Hoes, A. W. (2007) · Heart · doi:10.1136/hrt.2003.025270 · Cited by 1,922
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Roger, V. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.300268 · Cited by 1,728 · cited 1×
“Although these drugs have shown beneficial effects in terms of relieving symptoms and reducing mortality [4, 5], prognosis for HF patients remains poor, with 5- and 10-year mortality rates of 50 and 90 %, respectively [131].”
BackgroundFormation and function of the myofibroblast during tissue repair
Hinz, B. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700613 · Cited by 1,658
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Extracellular Matrix Assembly: A Multiscale Deconstruction
Mouw, J. K., Ou, G., & Weaver, V. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3902 · Cited by 1,534 · cited 1×
“Fibrosis is the excessive deposition of extracellular matrix (ECM), such as collagens and fibronectin, resulting in the excessive accumulation of fibrous connective tissue [1, 2].”
BackgroundDesmoulière, A., Redard, M., Darby, I. A., & Gabbiani, G. (1995) · Europe PMC (PubMed Central) · Cited by 1,448
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile Activity
Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., & Chaponnier, C. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.9.2730 · Cited by 1,288
Atrial Fibrosis: Mechanisms and Clinical Relevance in Atrial Fibrillation
Burstein, B., & Nattel, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.064 · Cited by 1,242
Recent Developments in Myofibroblast Biology
Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmoulière, A., Varga, J., De Wever, O., Mareel, M., & Gabbiani, G. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.004 · Cited by 1,193
Heart repair by reprogramming non-myocytes with cardiac transcription factors
Song, K., Nam, Y.-J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., et al. (2012) · Nature · doi:10.1038/nature11139 · Cited by 1,147
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P., & Schaper, J. (2003) · Circulation · doi:10.1161/01.cir.0000051865.66123.b7 · Cited by 1,102
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984
Structural and functional characterisation of cardiac fibroblasts
CAMELLITI, P., BORG, T., & KOHL, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.020 · Cited by 930
Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis
Kramann, R., Schneider, R. K., DiRocco, D. P., Machado, F., Fleig, S., Bondzie, P. A., Henderson, J. M., Ebert, B. L., & Humphreys, B. D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.004 · Cited by 922 · cited 2×
“Recently, Kramann et al. [55] identified glioma-associ-ated oncogene family zinc finger 1 (Gli1) positive perivascular mesenchymal stem cells (MSCs) as a source of myofibroblast cells in mouse tissue after induction of organ damage, including the pressure-overloaded heart (aortic banding).”
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
TGF-β Activation and Function in Immunity
Travis, M. A., & Sheppard, D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120257 · Cited by 856
Extracellular control of TGFβ signalling in vascular development and disease
ten Dijke, P., & Arthur, H. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2262 · Cited by 778
Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Jessup, M., Greenberg, B., Mancini, D., Cappola, T., Pauly, D. F., Jaski, B., Yaroshinsky, A., Zsebo, K. M., Dittrich, H., & Hajjar, R. J. (2011) · Circulation · doi:10.1161/circulationaha.111.022889 · Cited by 760
Heijman, J., Voigt, N., Nattel, S., & Dobrev, D. (2014) · Circulation Research · doi:10.1161/circresaha.114.302226 · Cited by 677
Myofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Inflammatory mediators in chronic heart failure: an overview
Anker, S. D., & von Haehling, S. (2004) · Heart · doi:10.1136/hrt.2002.007005 · Cited by 627
Brouwers, F. P., de Boer, R. A., van der Harst, P., Voors, A. A., Gansevoort, R. T., Bakker, S. J., Hillege, H. L., van Veldhuisen, D. J., & van Gilst, W. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht066 · Cited by 610
Self-citationde Boer, R. A., Lok, D. J. A., Jaarsma, T., van der Meer, P., Voors, A. A., Hillege, H. L., & van Veldhuisen, D. J. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.538080 · Cited by 592
Self-citationMolecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders
Piera-Velazquez, S., Li, Z., & Jimenez, S. A. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.06.001 · Cited by 580
Tsutamoto, T., Hisanaga, T., Wada, A., Maeda, K., Ohnishi, M., Fukai, D., Mabuchi, N., Sawaki, M., & Kinoshita, M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00494-4 · Cited by 561
Verheule, S., Sato, T., Everett, T., Engle, S. K., Otten, D., Rubart-von der Lohe, M., Nakajima, H. O., Nakajima, H., Field, L. J., & Olgin, J. E. (2004) · Circulation Research · doi:10.1161/01.res.0000129579.59664.9d · Cited by 547
Molecular basis of physiological heart growth: fundamental concepts and new players
Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536
Miyamoto, M. I., del Monte, F., Schmidt, U., DiSalvo, T. S., Kang, Z. B., Matsui, T., Guerrero, J. L., Gwathmey, J. K., Rosenzweig, A., & Hajjar, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.793 · Cited by 530
Structural correlate of atrial fibrillation in human patients
Kostin, S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00273-0 · Cited by 511
Reprogramming of human fibroblasts toward a cardiac fate
Nam, Y.-J., Song, K., Luo, X., Daniel, E., Lambeth, K., West, K., Hill, J. A., DiMaio, J. M., Baker, L. A., Bassel-Duby, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301019110 · Cited by 500
Cardiomyocyte death: mechanisms and translational implications
Chiong, M., Wang, Z. V., Pedrozo, Z., Cao, D. J., Troncoso, R., Ibacache, M., Criollo, A., Nemchenko, A., Hill, J. A., & Lavandero, S. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.130 · Cited by 491
Biernacka, A., & Frangogiannis, N. G. (2011) · Europe PMC (PubMed Central) · Cited by 484
Zeisberg, M., & Kalluri, R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00328.2012 · Cited by 462
C-Reactive Protein in Heart Failure: Prognostic Value and the Effect of Valsartan
Anand, I. S., Latini, R., Florea, V. G., Kuskowski, M. A., Rector, T., Masson, S., Signorini, S., Mocarelli, P., Hester, A., Glazer, R., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.508465 · Cited by 456
Basic mechanisms in heart failure: The cytokine hypothesis
Seta, Y., Shan, K., Bozkurt, B., Oral, H., & Mann, D. L. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80047-9 · Cited by 444
Meléndez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S., & Brower, G. L. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.148635 · Cited by 442
Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.971168 · Cited by 435
Self-citationBiomarkers and diagnostics in heart failure
Gaggin, H. K., & Januzzi, J. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.014 · Cited by 423
Latent Transforming Growth Factor-β (TGF-β) Binding Proteins: Orchestrators of TGF-β Availability
Rifkin, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r400029200 · Cited by 420
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
Creemers, E. E., & Pinto, Y. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq308 · Cited by 403
Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload
Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., Shindo, T., Sano, M., Otsu, K., Snider, P., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40295 · Cited by 389
Bogoyevitch, M. A., Glennon, P. E., Andersson, M. B., Clerk, A., Lazou, A., Marshall, C. J., Parker, P. J., & Sugden, P. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42228-9 · Cited by 388
Lineage and Morphogenetic Analysis of the Cardiac Valves
de Lange, F. J., Moorman, A. F. M., Anderson, R. H., Männer, J., Soufan, A. T., Vries, C. D. G.-D., Schneider, M. D., Webb, S., van den Hoff, M. J. B., & Christoffels, V. M. (2004) · Circulation Research · doi:10.1161/01.res.0000141429.13560.cb · Cited by 387
High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure
Ky, B., French, B., McCloskey, K., Rame, J. E., McIntosh, E., Shahi, P., Dries, D. L., Tang, W. H. W., Wu, A. H. B., Fang, J. C., et al. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.958223 · Cited by 376
Myocyte apoptosis in heart failure
VANEMPEL, V, BERTRAND, A., HOFSTRA, L., CRIJNS, H., DOEVENDANS, P., & DEWINDT, L. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.012 · Cited by 373
Segura, A. M., Frazier, O. H., & Buja, L. M. (2014) · Heart Failure Reviews · doi:10.1007/s10741-012-9365-4 · Cited by 371
Evolving Concepts of Apoptosis in Idiopathic Pulmonary Fibrosis
Thannickal, V. J., & Horowitz, J. C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-001tk · Cited by 364
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
Patrick, D. M., Montgomery, R. L., Qi, X., Obad, S., Kauppinen, S., Hill, J. A., van Rooij, E., & Olson, E. N. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43604 · Cited by 360
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation
Rudolph, V., Andrié, R. P., Rudolph, T. K., Friedrichs, K., Klinke, A., Hirsch-Hoffmann, B., Schwoerer, A. P., Lau, D., Fu, X., Klingel, K., et al. (2010) · Nature Medicine · doi:10.1038/nm.2124 · Cited by 349
Atrial fibrosis and the mechanisms of atrial fibrillation
Everett, T. H., & Olgin, J. E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2006.12.040 · Cited by 338
Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution.
Nag, A. C. (1980) · PubMed · Cited by 336
Regulation of endothelial cell plasticity by TGF-β
van Meeteren, L. A., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1222-6 · Cited by 333
Intramyocardial Fibroblast Myocyte Communication
Kakkar, R., & Lee, R. T. (2010) · Circulation Research · doi:10.1161/circresaha.109.207456 · Cited by 333
Ali, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Müller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 309
The role of IL-1 in the pathogenesis of heart disease
Bujak, M., & Frangogiannis, N. G. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0024-y · Cited by 307
Programmed Necrosis, Not Apoptosis, in the Heart
Kung, G., Konstantinidis, K., & Kitsis, R. N. (2011) · Circulation Research · doi:10.1161/circresaha.110.225730 · Cited by 291
Grotendorst, G. R., Rahmanie, H., & Duncan, M. R. (2004) · The FASEB Journal · doi:10.1096/fj.03-0699com · Cited by 291
Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
Anderton, M. J., Mellor, H. R., Bell, A., Sadler, C., Pass, M., Powell, S., Steele, S. J., Roberts, R. R. A., & Heier, A. (2011) · Toxicologic Pathology · doi:10.1177/0192623311416259 · Cited by 284
Ma, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., & Du, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035144 · Cited by 271
Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos
Lincoln, J., Alfieri, C. M., & Yutzey, K. E. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20051 · Cited by 271
The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism
Labrador, J. P., Azcoitia, V., Tuckermann, J., Lin, C., Olaso, E., Mañes, S., Brückner, K., Goergen, J., Lemke, G., Yancopoulos, G., et al. (2001) · EMBO reports · doi:10.1093/embo-reports/kve094 · Cited by 271
De Jong, A. M., Maass, A. H., Oberdorf-Maass, S. U., Van Veldhuisen, D. J., Van Gilst, W. H., & Van Gelder, I. C. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq357 · Cited by 269
Circulating Biomarkers of Myocardial Fibrosis
López, B., González, A., Ravassa, S., Beaumont, J., Moreno, M. U., San José, G., Querejeta, R., & Díez, J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.026 · Cited by 258
Strutz, F., Zeisberg, M., Renziehausen, A., Raschke, B., Becker, V., Van Kooten, C., & Müller, G. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002579.x · Cited by 250
Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling
Fu, H.-L., Valiathan, R. R., Arkwright, R., Sohail, A., Mihai, C., Kumarasiri, M., Mahasenan, K. V., Mobashery, S., Huang, P., Agarwal, G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.444158 · Cited by 245
MiR-125b Is Critical for Fibroblast-to-Myofibroblast Transition and Cardiac Fibrosis
Nagpal, V., Rai, R., Place, A. T., Murphy, S. B., Verma, S. K., Ghosh, A. K., & Vaughan, D. E. (2016) · Circulation · doi:10.1161/circulationaha.115.018174 · Cited by 244
Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling
Yamaguchi, O., Higuchi, Y., Hirotani, S., Kashiwase, K., Nakayama, H., Hikoso, S., Takeda, T., Watanabe, T., Asahi, M., Taniike, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136717100 · Cited by 224
van Amerongen, M., Bou‐Gharios, G., Popa, E., van Ark, J., Petersen, A., van Dam, G., van Luyn, M., & Harmsen, M. (2008) · The Journal of Pathology · doi:10.1002/path.2281 · Cited by 193
Plasma Myeloperoxidase Levels in Patients With Chronic Heart Failure
Tang, W. H. W., Brennan, M.-L., Philip, K., Tong, W., Mann, S., Van Lente, F., & Hazen, S. L. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.04.018 · Cited by 186
Kulasekaran, P., Scavone, C. A., Rogers, D. S., Arenberg, D. A., Thannickal, V. J., & Horowitz, J. C. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0447oc · Cited by 185
THE ROLE OF TNF IN CARDIOVASCULAR DISEASE
FERRARI, R. (1999) · Pharmacological Research · doi:10.1006/phrs.1998.0463 · Cited by 182
Edelmann, F., Holzendorf, V., Wachter, R., Nolte, K., Schmidt, A. G., Kraigher-Krainer, E., Duvinage, A., Unkelbach, I., Düngen, H.-D., Tschöpe, C., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.203 · Cited by 176
Noncoding RNAs and myocardial fibrosis
Thum, T. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.125 · Cited by 173
de Boer, M. P., Meijer, R. I., Wijnstok, N. J., Jonk, A. M., Houben, A. J. H. M., Stehouwer, C. D. A., Smulders, Y. M., Eringa, E. C., & Serné, E. H. (2011) · Microcirculation · doi:10.1111/j.1549-8719.2011.00130.x · Cited by 171
The Athlete's Heart vs. the Failing Heart: Can Signaling Explain the Two Distinct Outcomes?
Weeks, K. L., & McMullen, J. R. (2011) · Physiology · doi:10.1152/physiol.00043.2010 · Cited by 171
Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair
Virag, J. A. I., Rolle, M. L., Reece, J., Hardouin, S., Feigl, E. O., & Murry, C. E. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070003 · Cited by 170
Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation
Diwan, A., Wansapura, J., Syed, F. M., Matkovich, S. J., Lorenz, J. N., & Dorn, G. W. (2008) · Circulation · doi:10.1161/circulationaha.107.727073 · Cited by 168
Waltz Dancing in Patients With Chronic Heart Failure: New Form of Exercise Training
Belardinelli, R., Lacalaprice, F., Ventrella, C., Volpe, L., & Faccenda, E. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.765727 · Cited by 164
Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators
Cartledge, J. E., Kane, C., Dias, P., Tesfom, M., Clarke, L., Mckee, B., Al Ayoubi, S., Chester, A., Yacoub, M. H., Camelliti, P., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvu264 · Cited by 158
Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications
Ogawa, M., LaRue, A. C., & Drake, C. J. (2006) · Blood · doi:10.1182/blood-2006-04-016600 · Cited by 155
Kaye, D. M., Pimental, D. R., Prasad, S., Mäki, T., Berger, H. J. C., McNeil, P. L., Smith, T. W., & Kelly, R. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118414 · Cited by 152
The Cellular Derivation and the Life Span of the Myofibroblast
Gabbiani, G. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80092-6 · Cited by 147
González, J., Villalba‐Orero, M., Busnadiego, Ó., López-Olañeta, M. M., Sandoval, P., Snabel, J. M., López‐Cabrera, M., Erler, J. T., Hanemaaijer, R., Lara‐Pezzi, E., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv214 · Cited by 142
Tsagalou, E. P., ANASTASIOU‐NANA, M. I., Agapitos, E. B., Gika, A., Drakos, S. G., Terrovitis, J. V., Ntalianis, A. S., & Nanas, J. N. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.064 · Cited by 142
Distinct Pathways Regulate Proapoptotic Nix and BNip3 in Cardiac Stress
Galvez, A. S., Brunskill, E. W., Marreez, Y., Benner, B. J., Regula, K. M., Kirshenbaum, L. A., & Dorn, G. W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509056200 · Cited by 135
A novel approach to improve cardiac performance: cardiac myosin activators
Teerlink, J. R. (2009) · Heart Failure Reviews · doi:10.1007/s10741-009-9135-0 · Cited by 134
Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?
López, B., González, A., Lindner, D., Westermann, D., Ravassa, S., Beaumont, J., Gallego, I., Zudaire, A., Brugnolaro, C., Querejeta, R., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt100 · Cited by 132
Pellieux, C., Foletti, A., Peduto, G., Aubert, J.-F., Nussberger, J., Beermann, F., Brunner, H. R., & Pedrazzini, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13627 · Cited by 123
Engebretsen, K. V. T., Skårdal, K., Bjørnstad, S., Marstein, H. S., Skrbic, B., Sjaastad, I., Christensen, G., Bjørnstad, J. L., & Tønnessen, T. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.08.008 · Cited by 110
Reversible and irreversible differentiation of cardiac fibroblasts
Driesen, R. B., Nagaraju, C. K., Abi-Char, J., Coenen, T., Lijnen, P. J., Fagard, R. H., Sipido, K. R., & Petrov, V. V. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt338 · Cited by 107
Yamagami, K., Oka, T., Wang, Q., Ishizu, T., Lee, J., Miwa, K., Akazawa, H., Naito, A. T., Sakata, Y., & Komuro, I. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00137.2015 · Cited by 97
Ventricular remodelling: consequences and therapy
Sabbah, H. N., & Goldstein, S. (1993) · European Heart Journal · doi:10.1093/eurheartj/14.suppl_c.24 · Cited by 96
Wu, Q., Xu, M., Yuan, Y., Li, F.-F., Yang, Z., Liu, Y., Zhou, M.-Q., Bian, Z., Deng, W., Gao, L., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00601.2014 · Cited by 95
Herum, K. M., Lunde, I. G., Skrbic, B., Louch, W. E., Hasic, A., Boye, S., Unger, A., Brorson, S.-H., Sjaastad, I., Tønnessen, T., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv002 · Cited by 92
The role of inflammation in heart failure: new therapeutic approaches.
Oikonomou, E. K., Tousoulis, D., Siasos, G., Zaromitidou, M., Papavassiliou, A. G., & Stefanadis, C. (2011) · PubMed · Cited by 91
Bevegård, S., Jönsson, B., Karlöf, I., et al. (1967) · Cardiovascular Research · doi:10.1093/cvr/1.1.21 · Cited by 91
ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice
Liu, Q., Sargent, M. A., York, A. J., & Molkentin, J. D. (2009) · Circulation Research · doi:10.1161/circresaha.109.200741 · Cited by 80
Barton, P. J. R., Birks, E. J., Felkin, L. E., Cullen, M. E., Koban, M. U., & Yacoub, M. H. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00557-0 · Cited by 78
Cardiac myosin activation part 1: From concept to clinic
Malik, F. I., & Morgan, B. P. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.05.006 · Cited by 69
New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis
Ding, Q., Luckhardt, T., Hecker, L., Zhou, Y., Liu, G., Antony, V. B., deAndrade, J. A., & Thannickal, V. J. (2011) · Drugs · doi:10.2165/11591490-000000000-00000 · Cited by 68
House, S. L., House, B. E., Glascock, B. J., Kimball, T. F., Nusayr, E., Schultz, J. E. J., & Doetschman, T. (2010) · PubMed · doi:10.4255/mcpharmacol.10.20 · Cited by 63
Turner, N. A. (2013) · Vascular Pharmacology · doi:10.1016/j.vph.2013.06.002 · Cited by 60
Watanabe, T., Otsu, K., Takeda, T., Yamaguchi, O., Hikoso, S., Kashiwase, K., Higuchi, Y., Taniike, M., Nakai, A., Matsumura, Y., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.151 · Cited by 60
Heart repair by cardiac reprogramming
Nam, Y., Song, K., & Olson, E. N. (2013) · Nature Medicine · doi:10.1038/nm.3147 · Cited by 59
Rosker, C., Salvarani, N., Schmutz, S., Grand, T., & Rohr, S. (2011) · Circulation Research · doi:10.1161/circresaha.111.244798 · Cited by 57
Porter, K. M., Lin, Y., & Liton, P. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068668 · Cited by 56
Kapur, N. K. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.960054 · Cited by 53
Jayasankar, V., Woo, Y.-P. J., Bish, L. T., Pirolli, T. J., Berry, M. F., Burdick, J., Bhalla, R. C., Sharma, R. V., Gardner, T. J., & Sweeney, H. L. (2004) · Circulation · doi:10.1161/01.cir.0000138946.29375.49 · Cited by 49
Sawaki, D., Hou, L., Tomida, S., Sun, J., Zhan, H., Aizawa, K., Son, B., Kariya, T., Takimoto, E., Otsu, K., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv155 · Cited by 47
Omecamtiv mecarbil: a new cardiac myosin activator for the treatment of heart failure
Liu, L. C. Y., Dorhout, B., van der Meer, P., Teerlink, J. R., & Voors, A. A. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1123248 · Cited by 47
Kosla, J., Dvořáková, M., Dvořák, M., & Čermák, V. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.013 · Cited by 27
Targeting Sarcoplasmic Reticulum Calcium ATPase by Gene Therapy
Gwathmey, J. K., Yerevanian, A., & Hajjar, R. J. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.2512 · Cited by 27
Novel mechanisms for caspase inhibition protecting cardiac function with chronic pressure overload
Park, M., Vatner, S. F., Yan, L., Gao, S., Yoon, S., Lee, G. J. A., Xie, L., Kitsis, R. N., & Vatner, D. E. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0324-y · Cited by 21
Frazzetto, G. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400161 · Cited by 17
Nix Nought Nothing: Fairy tale or real deal
Dorn, G. W. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.011 · Cited by 16
Ren, A., Yan, X., Lu, H., Shi, J., Yin, Y., Bai, J., Yuan, W.-J., & Li, L. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-051 · Cited by 14
Cited by
Signaling pathways and targeted therapy for myocardial infarction
Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., Wang, Y., Fu, C., Jiang, Y., He, C., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00925-z · Cited by 831
Yurista, S. R., Silljé, H. H. W., Oberdorf-Maass, S. U., Schouten, E.-M., Pavez Giani, M. G., Hillebrands, J.-L., van Goor, H., van Veldhuisen, D. J., de Boer, R. A., & Westenbrink, B. D. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1473 · Cited by 321
Self-citationSuthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0343-y · Cited by 307
“Extensive cardiac fibrosis results in electro-mechanical disturbances and reduces nutrient supply toward the myocardium, perpetuating a vicious cycle of fibrosis, cell death and inflammation [51].”
BackgroundSelf-citationde Boer, R. A., De Keulenaer, G., Bauersachs, J., Brutsaert, D., Cleland, J. G., Diez, J., Du, X.-J., Ford, P., Heinzel, F. R., Lipson, K. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1406 · Cited by 304
Self-citationUhlig, M., Billig, S., Wienhold, J., & Schumacher, D. (2025) · Cells · doi:10.3390/cells14050345 · Cited by 29
“Additionally, fibrotic tissue disrupts normal electrical conduction, leading to arrhythmias such as atrial fibrillation and ventricular tachycardia, which may result in syncope or sudden cardiac death [26,28].”
Metadata
- Authors
- Piek, A., de Boer, R. A., & Silljé, H. H. W.
- Venue
- Heart Failure Reviews
- Published
- 2016-02-16
- Volume
- 21
- Issue
- 2
- Pages
- 199-211
- ISSN
- 1382-4147 (ISSN-L)
- 1573-7322
- OpenAlex
- W2280484610
- Cited by
- 301
- References
- 138
- FWCI
- 21.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.